PHARMA (30/11/2020) consolidating in ascending triangleIn H4, the stock is forming price action in ascending triangle pattern. Currently is consolidating between 5.42 and 5.80. A good entry would be after it breakout from the triangle @ EP 5.86 with Support at 5.38. TP is at 6.73 and new 52WH 8.25 (Fibo 1.272) - RRR 1:1.8
EP 5.86
TP 6.73 / 8.25
SL 5.38
Stochastic shows a pullback signal, MACD didn’t signal any breakout, and RSI didn’t show any good momentum for entry now.
PHARMA is one of market leader in Pharmaceutical sector with competitive balanced float (21% of 1440M shares) compared to its sector competitor AHEALTH (23% of 1780M shares). However, current vaccine sentiment will definitely help PHARMA in the long run.
TAYOR
Trade ideas
PHARMA - Falling Wedge with Prior UptrendOpportunity and Risk
DISCLAIMER: This technical analysis is for educational and informational purposes only. It is based on my personal view of the market from a technical standpoint. None of information posted in this page can be used as investment decisions except for educational purpose only. Do not trade solely on the information posted in this page. Trade at your own risk and judgement. A trader could potentially lose all money. Only risk capital that can be lost without jeopardizing ones financial security of lifestyle. Please seek licensed professional guidance if you plan to invest your capital seriously.
PENAFIAN: Analisis Teknikal ini hanyalah untuk tujuan pembelajaran & pendidikan sahaja dan bukan cadangan untuk membeli atau menjual stok atau apa jua jenis instrumen kewangan. Anda dinasihatkan untuk menghubungi remieser / dealer / bank pelaburan yang mempunyai lesen atau kelayakan yang sah untuk bertanyakan pendapat dan menguruskan pelaburan anda. Pelaburan dan perdagangan mempunyai risiko tinggi, dan ianya adalah Risiko Anda Sendiri.
<TradeVSA> Smart Money in PharmaniagaStrength in the chart:
1. Shakeout
2. High volume at the bottom
3. High volume gap up
Disclaimer
This information only serves as reference information and does not constitute a buy or sell call. Conduct your own research and assessment before deciding to buy or sell any stock











